Open Label Continuation Study in Moderate to Severe Psoriasis
NCT ID: NCT00626002
Last Updated: 2013-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
2301 participants
INTERVENTIONAL
2008-02-29
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00570986
A Study of Safety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis
NCT00679731
Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00292396
Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00691964
Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00710580
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
ABT-874
100mg ABT-874 administered SQ every 4 wks for approximately 204 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ABT-874
100mg ABT-874 administered SQ every 4 wks for approximately 204 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject has a clinical diagnosis of moderate to severe plaque psoriasis
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AbbVie (prior sponsor, Abbott)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin Kaul, MD
Role: STUDY_CHAIR
AbbVie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Site Reference ID/Investigator# 7496
Birmingham, Alabama, United States
Site Reference ID/Investigator# 8438
Birmingham, Alabama, United States
Site Reference ID/Investigator# 7522
Huntsville, Alabama, United States
Site Reference ID/Investigator# 7774
Scottsdale, Arizona, United States
Site Reference ID/Investigator# 7435
Tucson, Arizona, United States
Site Reference ID/Investigator# 7933
Little Rock, Arkansas, United States
Site Reference ID/Investigator# 7234
Bakersfield, California, United States
Site Reference ID/Investigator# 8249
Fresno, California, United States
Site Reference ID/Investigator# 7332
Irvine, California, United States
Site Reference ID/Investigator# 7239
Los Angeles, California, United States
Site Reference ID/Investigator# 8390
Oceanside, California, United States
Site Reference ID/Investigator# 7503
San Diego, California, United States
Site Reference ID/Investigator# 7520
San Diego, California, United States
Site Reference ID/Investigator# 7010
San Diego, California, United States
Site Reference ID/Investigator# 10962
San Francisco, California, United States
Site Reference ID/Investigator# 7334
Santa Monica, California, United States
Site Reference ID/Investigator# 7793
Vallejo, California, United States
Site Reference ID/Investigator# 7929
Denver, Colorado, United States
Site Reference ID/Investigator# 7436
Longmont, Colorado, United States
Site Reference ID/Investigator# 7521
New Haven, Connecticut, United States
Site Reference ID/Investigator# 7653
Doral, Florida, United States
Site Reference ID/Investigator# 8341
Jacksonville, Florida, United States
Site Reference ID/Investigator# 7716
Miami, Florida, United States
Site Reference ID/Investigator# 7657
Miami, Florida, United States
Site Reference ID/Investigator# 10841
South Miami, Florida, United States
Site Reference ID/Investigator# 7893
West Palm Beach, Florida, United States
Site Reference ID/Investigator# 7331
Alpharetta, Georgia, United States
Site Reference ID/Investigator# 9743
Atlanta, Georgia, United States
Site Reference ID/Investigator# 7891
Newnan, Georgia, United States
Site Reference ID/Investigator# 7932
Snellville, Georgia, United States
Site Reference ID/Investigator# 8379
Arlington Heights, Illinois, United States
Site Reference ID/Investigator# 8798
Maywood, Illinois, United States
Site Reference ID/Investigator# 10703
Schaumburg, Illinois, United States
Site Reference ID/Investigator# 6950
Skokie, Illinois, United States
Site Reference ID/Investigator# 7892
West Dundee, Illinois, United States
Site Reference ID/Investigator# 6933
Indianapolis, Indiana, United States
Site Reference ID/Investigator# 10422
Indianapolis, Indiana, United States
Site Reference ID/Investigator# 16581
Plainfield, Indiana, United States
Site Reference ID/Investigator# 7992
Overland Park, Kansas, United States
Site Reference ID/Investigator# 17193
Henderson, Kentucky, United States
Site Reference ID/Investigator# 8528
Louisville, Kentucky, United States
Site Reference ID/Investigator# 9962
Owensboro, Kentucky, United States
Site Reference ID/Investigator# 8529
Andover, Massachusetts, United States
Site Reference ID/Investigator# 8149
Boston, Massachusetts, United States
Site Reference ID/Investigator# 9823
Detroit, Michigan, United States
Site Reference ID/Investigator# 7883
Fort Gratiot, Michigan, United States
Site Reference ID/Investigator# 7238
Grand Blanc, Michigan, United States
Site Reference ID/Investigator# 7656
Fridley, Minnesota, United States
Site Reference ID/Investigator# 6930
St Louis, Missouri, United States
Site Reference ID/Investigator# 6949
St Louis, Missouri, United States
Site Reference ID/Investigator# 7240
Omaha, Nebraska, United States
Site Reference ID/Investigator# 9567
Omaha, Nebraska, United States
Site Reference ID/Investigator# 7757
Berlin, New Jersey, United States
Site Reference ID/Investigator# 7330
East Windsor, New Jersey, United States
Site Reference ID/Investigator# 7882
New Brunswick, New Jersey, United States
Site Reference ID/Investigator# 7455
Albuquerque, New Mexico, United States
Site Reference ID/Investigator# 8078
Buffalo, New York, United States
Site Reference ID/Investigator# 8392
New York, New York, United States
Site Reference ID/Investigator# 8006
New York, New York, United States
Site Reference ID/Investigator# 7230
New York, New York, United States
Site Reference ID/Investigator# 10201
New York, New York, United States
Site Reference ID/Investigator# 8037
Rochester, New York, United States
Site Reference ID/Investigator# 7333
Stoney Brook, New York, United States
Site Reference ID/Investigator# 7434
Hickory, North Carolina, United States
Site Reference ID/Investigator# 8117
Wilmington, North Carolina, United States
Site Reference ID/Investigator# 9681
Winston-Salem, North Carolina, United States
Site Reference ID/Investigator# 6945
Cincinnati, Ohio, United States
Site Reference ID/Investigator# 23345
Cincinnati, Ohio, United States
Site Reference ID/Investigator# 7044
Cleveland, Ohio, United States
Site Reference ID/Investigator# 7899
Columbus, Ohio, United States
Site Reference ID/Investigator# 8389
Dayton, Ohio, United States
Site Reference ID/Investigator# 11181
Oklahoma City, Oklahoma, United States
Site Reference ID/Investigator# 6936
Lake Oswego, Oregon, United States
Site Reference ID/Investigator# 7703
Portland, Oregon, United States
Site Reference ID/Investigator# 6948
Portland, Oregon, United States
Site Reference ID/Investigator# 11424
Portland, Oregon, United States
Site Reference ID/Investigator# 8494
Hershey, Pennsylvania, United States
Site Reference ID/Investigator# 7930
Philadelphia, Pennsylvania, United States
Site Reference ID/Investigator# 6934
Johnston, Rhode Island, United States
Site Reference ID/Investigator# 6935
Providence, Rhode Island, United States
Site Reference ID/Investigator# 7785
Greer, South Carolina, United States
Site Reference ID/Investigator# 7497
Goodlettsville, Tennessee, United States
Site Reference ID/Investigator# 7388
Knoxville, Tennessee, United States
Site Reference ID/Investigator# 6931
Nashville, Tennessee, United States
Site Reference ID/Investigator# 7684
Arlington, Texas, United States
Site Reference ID/Investigator# 10842
Austin, Texas, United States
Site Reference ID/Investigator# 7498
Dallas, Texas, United States
Site Reference ID/Investigator# 6947
Dallas, Texas, United States
Site Reference ID/Investigator# 6944
Houston, Texas, United States
Site Reference ID/Investigator# 7758
San Antonio, Texas, United States
Site Reference ID/Investigator# 8108
San Antonio, Texas, United States
Site Reference ID/Investigator# 6937
Tyler, Texas, United States
Site Reference ID/Investigator# 7655
Webster, Texas, United States
Site Reference ID/Investigator# 10207
Salt Lake City, Utah, United States
Site Reference ID/Investigator# 6946
Norfolk, Virginia, United States
Site Reference ID/Investigator# 6932
Seattle, Washington, United States
Site Reference ID/Investigator# 10306
Spokane, Washington, United States
Site Reference ID/Investigator# 7884
Milwaukee, Wisconsin, United States
Site Reference ID/Investigator# 16845
Graz, , Austria
Site Reference ID/Investigator# 18183
Vienna, , Austria
Site Reference ID/Investigator# 15761
Brussels, , Belgium
Site Reference ID/Investigator# 7991
Barrie, , Canada
Site Reference ID/Investigator# 8047
Calgary, , Canada
Site Reference ID/Investigator# 7996
Edmonton, , Canada
Site Reference ID/Investigator# 6996
Halifax, , Canada
Site Reference ID/Investigator# 7236
Hamilton, , Canada
Site Reference ID/Investigator# 6995
Laval, , Canada
Site Reference ID/Investigator# 6998
London, , Canada
Site Reference ID/Investigator# 7043
London, , Canada
Site Reference ID/Investigator# 7329
Markham, , Canada
Site Reference ID/Investigator# 6999
Montreal, , Canada
Site Reference ID/Investigator# 7652
Montreal, , Canada
Site Reference ID/Investigator# 7006
North Bay, , Canada
Site Reference ID/Investigator# 8102
Ottawa, , Canada
Site Reference ID/Investigator# 6993
Québec, , Canada
Site Reference ID/Investigator# 8112
St. John's, , Canada
Site Reference ID/Investigator# 7931
Surrey, , Canada
Site Reference ID/Investigator# 8118
Vancouver, , Canada
Site Reference ID/Investigator# 6997
Vancouver, , Canada
Site Reference ID/Investigator# 6994
Waterloo, , Canada
Site Reference ID/Investigator# 8111
Westmount, , Canada
Site Reference ID/Investigator# 7005
Windsor, , Canada
Site Reference ID/Investigator# 7979
Windsor, , Canada
Site Reference ID/Investigator# 8348
Winnipeg, , Canada
Site Reference ID/Investigator# 17781
Aarhus, , Denmark
Site Reference ID/Investigator# 18041
Copenhagen NV, , Denmark
Site Reference ID/Investigator# 18661
Helsinki, , Finland
Site Reference ID/Investigator# 18701
Kuopio, , Finland
Site Reference ID/Investigator# 14962
Lahti, , Finland
Site Reference ID/Investigator# 19241
Turku, , Finland
Site Reference ID/Investigator# 18502
Nice, , France
Site Reference ID/Investigator# 16781
Paris, , France
Site Reference ID/Investigator# 18506
Toulouse, , France
Site Reference ID/Investigator# 16281
Berlin, , Germany
Site Reference ID/Investigator# 15664
Frankfurt am Main, , Germany
Site Reference ID/Investigator# 15663
Hamburg, , Germany
Site Reference ID/Investigator# 16381
Kiel, , Germany
Site Reference ID/Investigator# 16143
Munich, , Germany
Site Reference ID/Investigator# 16161
Münster, , Germany
Site Reference ID/Investigator# 17676
Tübingen, , Germany
Site Reference ID/Investigator# 16282
Athens, , Greece
Site Reference ID/Investigator# 15921
Athens, , Greece
Site Reference ID/Investigator# 15922
Thessaloniki, , Greece
Site Reference ID/Investigator# 15401
Modena, , Italy
Site Reference ID/Investigator# 14881
Rome, , Italy
Site Reference ID/Investigator# 19322
Barcelona, , Spain
Site Reference ID/Investigator# 15341
Madrid, , Spain
Site Reference ID/Investigator# 16142
Stockholm, , Sweden
Site Reference ID/Investigator# 17721
Geneva, , Switzerland
Site Reference ID/Investigator# 16749
Zurich, , Switzerland
Site Reference ID/Investigator# 19045
Aberdeen, , United Kingdom
Site Reference ID/Investigator# 15422
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-005955-40
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
M10-016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.